Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Sell
44
PLX Quote, Financials, Valuation and Earnings
Last price:
$2.48
Seasonality move
:
3.22%
Day range:
$2.30 - $2.49
52-week range:
$0.82 - $2.76
Dividend yield:
0%
P/E ratio:
83.00x
P/S ratio:
3.87x
P/B ratio:
4.50x
Volume:
677.8K
Avg. volume:
711.3K
1-year change:
88.64%
Market cap:
$194.3M
Revenue:
$53.4M
EPS (TTM):
$0.03
Earnings Data
Next earnings date for PLX
May 09
2025
Most recent earnings per share
$0.09
Beat by $0.09
(Mar 17/2025)
Consensus Estimate
--
(Mar 17/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PLX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | $21.6M | -- | -- | -- | -- |
| 03/17/2025 | Q4 | $18.7M | $18.2M | $0.09 | -- | -- |
| 11/14/2024 | Q3 | $16.3M | $18M | $0.03 | -- | -- |
| 08/14/2024 | Q2 | $12.5M | $13.5M | -$0.03 | -- | -- |
| 05/10/2024 | Q1 | $9.2M | $3.7M | -$0.06 | -- | -- |
| 03/14/2024 | Q4 | $8.1M | $10.5M | -$0.10 | -- | -- |
| 11/06/2023 | Q3 | -- | -- | -$0.04 | -- | -- |
| 08/07/2023 | Q2 | -- | -- | $0.21 | -- | -- |
| 05/04/2023 | Q1 | -- | -- | -$0.05 | -- | -- |
| 02/27/2023 | Q4 | -- | -- | -$0.07 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$0.07 | -- | -- |
| 08/15/2022 | Q2 | -- | -- | -$0.11 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.05 | -- | -- |
| 03/31/2022 | Q4 | -- | -- | -$0.14 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.09 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$0.14 | -- | -- |
| 03/30/2021 | Q4 | -- | -- | $0.03 | -- | -- |
| 10/29/2020 | Q3 | -- | -- | -$0.14 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$0.13 | -- | -- |
| 06/01/2020 | Q1 | -- | -- | $0.10 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | $0.02 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$0.52 | -- | -- |
| 05/06/2019 | Q1 | -- | -- | -$0.50 | -- | -- |
| 03/14/2019 | Q4 | -- | -- | -$0.40 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$0.60 | -- | -- |
| 05/09/2018 | Q1 | -- | -- | -$0.50 | -- | -- |
| 03/06/2018 | Q4 | -- | -- | -$0.87 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.90 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.60 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | -$4.80 | -- | -- |
| 03/16/2017 | Q4 | -- | -- | -$0.20 | -- | -- |
| 11/09/2016 | Q3 | -- | -- | -$0.70 | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -$1.10 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.90 | -- | -- |
| 03/08/2016 | Q4 | -- | -- | $7.70 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/10/2015 | Q2 | -- | -- | -$0.50 | -- | -- |
| 05/07/2015 | Q1 | -- | -- | -$0.60 | -- | -- |
Protalix BioTherapeutics Earnings Questions
-
How Much did Protalix BioTherapeutics Generate in Revenue Last Quarter?
Protalix BioTherapeutics reported $18.2M worth of top line sales in its most recent quarter.
-
Did Protalix BioTherapeutics Beat Earnings Last Quarter?
Protalix BioTherapeutics announced earnings per share of $0.09 which represents a beat of analyst forecast a -- per share.
-
Is Protalix BioTherapeutics Profitable?
Protalix BioTherapeutics reported $14.3M that represents $0.14 per share over the last quarter.
-
What is the Analyst Consensus for Protalix BioTherapeutics EPS Next Year?
Protalix BioTherapeutics's earnings are forecast to grow from $0.04 per share to -- per share next year representing an increase of --.
-
When is Protalix BioTherapeutics's Earnings Date?
Protalix BioTherapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
